Results: << | 101-125 | 126-150 | 151-175 | 176-200 | >>

Table of contents of journal: *Alimentary pharmacology and therapeutics

Results: 101-125/1697

Authors: Vreeburg, EM Levi, M Rauws, EAJ Deventer, SJHV Snel, P Bartelsman, JWFM Ten Cate, JW Tytgat, GNJ
Citation: Em. Vreeburg et al., Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhageand the beneficial effect of acid suppression, ALIM PHARM, 15(5), 2001, pp. 639-646

Authors: Katz, PO Xue, S Castell, DO
Citation: Po. Katz et al., Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg, ALIM PHARM, 15(5), 2001, pp. 647-652

Authors: Coulie, B Camilleri, M Bharucha, AE Sandborn, WJ Burton, D
Citation: B. Coulie et al., Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine an colonic motility in patients and healthy subjects, ALIM PHARM, 15(5), 2001, pp. 653-663

Authors: McCormack, G O'Donoghue, D Baird, A
Citation: G. Mccormack et al., In-vitro cyclosporin sensitivity of proliferating lymphocytes is predictive of in-vivo therapeutic response in ulcerative colitis, ALIM PHARM, 15(5), 2001, pp. 665-668

Authors: Metz, DC Buchanan, M Purich, E Fein, S
Citation: Dc. Metz et al., A randomized controlled crossover study comparing synthetic porcine and human secretins with biologically derived porcine secretin to diagnose Zollinger-Ellison Syndrome, ALIM PHARM, 15(5), 2001, pp. 669-676

Authors: Pohle, T Brzozowski, T Becker, JC Van der Voort, IR Markmann, A Konturek, SJ Moniczewski, A Domschke, W Konturek, JW
Citation: T. Pohle et al., Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C, ALIM PHARM, 15(5), 2001, pp. 677-687

Authors: Papatheodoridis, GV Papadimitropoulos, VC Hadziyannis, SJ
Citation: Gv. Papatheodoridis et al., Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis., ALIM PHARM, 15(5), 2001, pp. 689-698

Authors: Graham, DY Reddy, S
Citation: Dy. Graham et S. Reddy, Rapid detection of anti-Helicobacter pylori IgG in urine using immunochromatography, ALIM PHARM, 15(5), 2001, pp. 699-702

Authors: Szeto, ML Lee, CK Yee, YK Li, KF Lee, WK Lee, CC Que, TL Wong, BCY
Citation: Ml. Szeto et al., Evaluation of five commercial serological tests for the detection of Helicobacter pylori infection in Chinese, ALIM PHARM, 15(5), 2001, pp. 703-706

Authors: Tankovic, J Lamarque, D Lascols, C Soussy, CJ Delchier, JC
Citation: J. Tankovic et al., Impact of Helicobacter pylori resistance to clarithromycin on the efficacyof the omeprazole-amoxcillin-clarithromycin therapy, ALIM PHARM, 15(5), 2001, pp. 707-713

Authors: Suzuki, H Mori, M Seto, K Miyazawa, M Kai, A Suematsu, M Yoneta, T Miura, S Ishii, H
Citation: H. Suzuki et al., Polaprezinc attenuates the Helicobacter pylori-induced gastric mucosal leucocyte activation in Mongolian gerbils - a study using intravital videomicroscopy, ALIM PHARM, 15(5), 2001, pp. 715-725

Authors: Beales, ILP
Citation: Ilp. Beales, H-pylori-gastrin link in malt lymphoma, ALIM PHARM, 15(5), 2001, pp. 727-728

Authors: Konturek, SJ
Citation: Sj. Konturek, H-pylori-gastrin link in malt lymphoma - Reply, ALIM PHARM, 15(5), 2001, pp. 728-729

Authors: Waldum, HL
Citation: Hl. Waldum, H-pylori-gastrin link in malt lymphoma, ALIM PHARM, 15(5), 2001, pp. 729-730

Authors: Oldenburg, B Koningsberger, JC Henegouwen, GPV Van Asbeck, BS Marx, JJM
Citation: B. Oldenburg et al., Review article: iron and inflammatory bowel disease., ALIM PHARM, 15(4), 2001, pp. 429-438

Authors: Zar, S Kumar, D Benson, MJ
Citation: S. Zar et al., Review article: food hypersensitivity and irritable bowel syndrome, ALIM PHARM, 15(4), 2001, pp. 439-449

Authors: Souza, RF
Citation: Rf. Souza, Review article: a molecular rationale for the how, when and why of colorectal cancer screening, ALIM PHARM, 15(4), 2001, pp. 451-462

Authors: Cornillie, F Shealy, D D'Haens, G Geboes, K Van Assche, G Ceuppens, J Wagner, C Schaible, T Plevy, SE Targan, SR Rutgeerts, P
Citation: F. Cornillie et al., Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease, ALIM PHARM, 15(4), 2001, pp. 463-473

Authors: Blomqvist, P Feltelius, N Lofberg, R Ekbom, A
Citation: P. Blomqvist et al., A 10-year survey of inflammatory bowel diseases - drug therapy, costs and adverse reactions, ALIM PHARM, 15(4), 2001, pp. 475-481

Authors: Norgard, B Czeizel, AE Rockenbauer, M Olsen, J Sorensen, HT
Citation: B. Norgard et al., Population-based case control study of the safety of sulfasalazine use during pregnancy, ALIM PHARM, 15(4), 2001, pp. 483-486

Authors: Osato, MS Reddy, SG Piergies, AA Bochenek, WJ Testa, RT Graham, DY
Citation: Ms. Osato et al., Comparative efficacy of new investigational agents against Helicobacter pylori, ALIM PHARM, 15(4), 2001, pp. 487-492

Authors: Wong, BCY Wang, WH Berg, DE Fung, FMY Wong, KW Wong, WM Lai, KC Cho, CH Hui, WM Lam, SK
Citation: Bcy. Wong et al., High prevalence of mixed infections by Helicobacter pylori in Hong Kong: metronidazole sensitivity and overall genotype, ALIM PHARM, 15(4), 2001, pp. 493-503

Authors: Wong, BCY Wong, WM Wang, WH Tang, VSY Young, J Lai, KC Yuen, ST Leung, SY Hu, WHC Chan, CK Hui, WM Lam, SK
Citation: Bcy. Wong et al., An evaluation of invasive and non-invasive tests for the diagnosis of Helicobacter pylori infection in Chinese, ALIM PHARM, 15(4), 2001, pp. 505-511

Authors: Graham, DY Saeed, MA Hoffman, J El-Zimaity, HMT Kwon, DH Osato, MS
Citation: Dy. Graham et al., Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effectof metronidazole resistance, ALIM PHARM, 15(4), 2001, pp. 513-518

Authors: Srinivasan, R Katz, PO Ramakrishnan, A Katzka, DA Vela, MF Castell, DO
Citation: R. Srinivasan et al., Maximal acid reflux control for Barrett's oesophagus: feasible and effective, ALIM PHARM, 15(4), 2001, pp. 519-524
Risultati: << | 101-125 | 126-150 | 151-175 | 176-200 | >>